Active surveillance (AS) is an important management option for men with low risk, clinically localized prostate cancer.
The clinical parameters for patient selection and definition of progression for AS protocols are evolving as data from several large cohorts become mature. Vital to this process is the critical role pathologic parameters play in identifying appropriate candidates for AS. These findings need to be reproducible and accurately reported by pathologists. Repeated biopsy after initial diagnosis of prostate cancer is recommended before inclusion in active surveillance for early detection of significant cancer.
Written by:
Mazzucchelli R, Galosi AB, Lopez-Beltran A, Scarpelli M, Cheng L, Montironi R. Are you the author?
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona.
Reference: Arch Ital Urol Androl. 2014 Dec 30;86(4):314-8.
doi: 10.4081/aiua.2014.4.314
PubMed Abstract
PMID: 25641461